Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over one-third of the global population, representing one of the most prevalent chronic liver diseases
Perspectives in GLP-1 research: new targets
2 However, large-scale, real-world data comparing the effects of GLP-1 RAs with other antihyperglycemic medications on psoriasis disease severity and treatment escalation among patients with comorbid T2DM remains limited
Interestingly, in clinical trials for 2.4 mg semaglutide, only 0.2% of 407 participants reported a burning sensation, which highlights the importance of proper injection technique
Compounded semaglutide contains the same active ingredient as brand products and produces identical weight loss results when prescribed at equivalent doses
The metabolic improvements and weight loss achieved with incretin-based therapies are associated with improved fertility